Literature DB >> 16409485

Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis.

X-X Wu, S S Pierangeli, J H Rand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16409485     DOI： 10.1111/j.1538-7836.2005.01700.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.

Authors:  Beverley J Hunt; Xiao-Xuan Wu; Bas de Laat; Alan A Arslan; Sara Stuart-Smith; Jacob H Rand
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 8.661

2.  Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Anthony W Ashton; Pojen P Chen; James J Hathcock; Harry A M Andree; Douglas J Taatjes
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

3.  Pathophysiological mechanisms in antiphospholipid syndrome.

Authors:  Brock E Harper; Rohan Wills; Silvia S Pierangeli
Journal:  Int J Clin Rheumtol       Date:  2011-04-01

Review 4.  Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?

Authors:  Yu Zuo; Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.